COVID-19 vaccine review finds ‘insufficient’ evidence for boosters A new article published in The Lancet has queried whether enough reliable data exists for booster programs despite their early adoption in several countries.
COVID-19 vaccine efficacy fades over time: Study Vaccine-induced immunity against infection appears to slowly reduce as months pass, but evidence around hospitalisation is less clear. What does this mean for boosters in Australia?
COVID surges in one of world’s most vaccinated nations But while case numbers in Iceland are at record levels, no deaths have been attributed to the most recent wave and hospitalisations remain low.
Mixing COVID vaccines could result in stronger immune response New research suggests mixing one dose of AstraZeneca with either Pfizer or Moderna could be beneficial. Is it something Australia should consider?
Herd immunity likely to be ‘made harder’ by variants New modelling has underlined the increasing scale of Australia’s vaccination challenge as it aims to open up to the world.
Why global COVID vaccination rates matter to Australia There has been a huge focus on issues plaguing the national vaccine rollout, but some of the country’s foremost experts say trends emerging in other parts of the world are equally concerning.
Evidence suggests COVID vaccines are protective against Delta strain Of 12,383 people admitted to UK hospitals with the recently identified variant of concern, only three had been fully vaccinated with two doses.
mRNA COVID vaccine ‘well-tolerated’ in adolescents According to Pfizer, its vaccine is safe and effective in children as young as 12, which could be crucial for herd immunity.
Kids’ immune systems a protective factor against severe COVID New research offers fresh insight into why most children with COVID-19 don’t get as sick adults.
How a ‘lower-efficacy’ vaccine could take us to herd immunity Some have claimed highly effective mRNA vaccines are the only available candidates that would allow Australia to reach herd immunity against COVID-19. But what if there’s another way?